NCEH1 promotes breast cancer progression by regulating NRP1 and activating the TNF-α/NF-κB signalling pathway

Key Points

• NCEH1 leads to breast cancer progression by regulating NRP1 and activating the TNF-α/NF-κB signalling pathway,
• The study identifies NCEH1 as a potential novel biomarker for breast cancer, highlighting its therapeutic potential.
• Observational analysis shows that targeting the NCEH1 pathway may slow down cancer progression.
• Findings indicate that more research on NCEH1 could improve therapeutic strategies for breast cancer.],